da Silva Jorge Santos

Insider Reports History

Location
Zug, Switzerland
Signature
/s/ Matthias Bodenstedt, Attorney-in-fact for Jorge Santos da Silva
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by da Silva Jorge Santos:

Company Role Class Num Shares Value Price $ Report Date Ownership
MoonLake Immunotherapeutics Chief Executive Officer, Director Class A ordinary shares, par value $0.0001 per share 3,074,893 $42,433,523 $13.80 19 Dec 2025 Direct
MoonLake Immunotherapeutics Chief Executive Officer, Director Stock Option (Right to Buy) 520,342 07 Jan 2026 Direct
MoonLake Immunotherapeutics Chief Executive Officer, Director Class C ordinary shares, par value $0.0001 per share 0 19 Dec 2025 Direct
MoonLake Immunotherapeutics Chief Executive Officer, Director Common shares, par value CHF 0.10 per share, of MoonLake AG 0 19 Dec 2025 Direct

Insider Reports Filed by da Silva Jorge Santos

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MLTX MoonLake Immunotherapeutics 07 Jan 2026 1 $0 4 Chief Executive Officer, Director 09 Jan 2026, 16:01
MLTX MoonLake Immunotherapeutics 19 Dec 2025 3 $0 4 Chief Executive Officer, Director 22 Dec 2025, 16:01
MLTX MoonLake Immunotherapeutics 08 Dec 2025 2 -$2,974,700 4 Chief Executive Officer, Director 10 Dec 2025, 16:29
MLTX MoonLake Immunotherapeutics 27 Feb 2025 1 $0 4 Chief Executive Officer, Director 03 Mar 2025, 21:08
MLTX MoonLake Immunotherapeutics 27 Feb 2024 3 -$6,803,044 4 Chief Executive Officer, Director 29 Feb 2024, 19:56
MLTX MoonLake Immunotherapeutics 21 Feb 2024 1 -$62,179 4 Chief Executive Officer, Director 23 Feb 2024, 16:48
MLTX MoonLake Immunotherapeutics 15 Feb 2024 3 -$3,555,400 4 Chief Executive Officer, Director 20 Feb 2024, 18:36
MLTX MoonLake Immunotherapeutics 01 Oct 2023 6 $0 4 Chief Executive Officer, Director 03 Oct 2023, 19:28
MLTX MoonLake Immunotherapeutics 05 Apr 2022 0 $0 3 Chief Executive Officer, Director 15 Apr 2022, 16:07